Vecamyl — United Healthcare
moderately severe to severe essential hypertension
Initial criteria
- Diagnosis of moderately severe to severe essential hypertension OR diagnosis of uncomplicated malignant hypertension
Reauthorization criteria
- Documentation of a positive clinical response to Vecamyl therapy
Approval duration
12 months